Temple Faculty Physicians is experiencing technical issues with phone lines. If you are experiencing an emergency, please visit your nearest emergency room. If you would like to schedule an appointment with your provider or have general questions or requests, please contact us by using myTempleHealth.

myTempleHealth
800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH

Coverage of the Coronavirus Pandemic for the Week Ending March 5th

View All News

Temple University Health System’s preparations for and treatment of patients amidst the coronavirus pandemic continue to be part of the media’s COVID-19 coverage.

  • Tony S. Reed, MD, MBA, Executive Vice President and Chief Medical Officer of Temple University Health System and Temple University Hospital, spoke with WHYY about utilizing Temple’s online portal as well as phone calls to contact patients and register them for the coronavirus vaccine.
  • Dr. Reed also spoke with the Philadelphia Inquirer about Temple’s ability to scale up and administer more vaccine doses if requested by the city of Philadelphia.
  • And, Dr. Reed also offered insight to the Temple News about coronavirus vaccine supply and vaccination efforts among staff and patients, among other topics.
  • The Philadelphia Inquirer interviewed Nina Gentile, MD, Professor and Research Director in the Department of Emergency Medicine at the Lewis Katz School of Medicine at Temple University, about the Johnson & Johnson COVID-19 vaccine and how it compares to those from Pfizer and Moderna. Dr. Gentile led the Temple University Hospital site of the Janssen Pharmaceutical Companies of Johnson & Johnson’s Phase 3 clinical research study to evaluate the safety and efficacy of its investigational COVID-19 vaccine candidate.
  • Jessica Jackson, MD, Assistant Professor of Clinical Emergency Medicine at the Lewis Katz School of Medicine at Temple University, also joined 6ABC in two segments to discuss the Johnson & Johnson vaccine and put it in perspective compared to those from Pfizer and Moderna. Dr. Jackson helped oversee the trial at Temple University Hospital. The Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for the vaccine on February 27th.
  • Gary S. Cohen, MD, FSIR, Herbert M. Stauffer Chair of Diagnostic Imaging and Professor of Radiology at the Lewis Katz School of Medicine at Temple University and Radiologist-in-Chief of Temple University Health System, offered insight to Reuters Health on recommendations published in Radiology about best practices for performing imaging such as mammograms, breast MRI, chest and neck CT, and PET scans following vaccination for COVID-19. The Moderna and Pfizer vaccines can cause temporary swelling in lymph nodes. Dr. Cohen was not involved in the Radiology recommendations. The Reuters Health article was picked up by MD Alert and Medscape.
  • A Philadelphia Business Journal article examining charitable giving at area universities during the COVID-19 pandemic highlighted the $5 million gift from Gerald M. Lemole, MD, a 1962 graduate of the Lewis Katz School of Medicine at Temple University (LKSOM) and Emily Jane Lemole to LKSOM to establish the Lemole Center for Integrated Lymphatics Research.
  • Beverley Zuccarello, a Physician Assistant in the Gastroenterology Department at Temple University Hospital, shared her COVID-19 vaccination experience with WHYY and how ongoing conversations about the topic convinced her parents to receive the vaccine from the Black Doctors COVID-19 Consortium 24-hour clinic at Temple’s Liacouras Center.
  • Students from Mathematics, Civics and Sciences Charter School donated PPE to Temple University Hospital on March 2nd. The school’s founder is a Temple graduate. CBS3 and 6ABC captured the delivery.